Literature DB >> 22523201

CNS infections, sepsis and risk of Parkinson's disease.

Fang Fang1, Karin Wirdefeldt, Andreas Jacks, Freya Kamel, Weimin Ye, Honglei Chen.   

Abstract

BACKGROUND: Neuroinflammation may play an important role in the aetiology of Parkinson's disease (PD); however, little is known about infections in relation to future PD risk.
METHODS: We conducted a register-based nested case-control study in Sweden to examine infections of the central nervous system (CNS) and sepsis in relation to PD with 18,648 patients and 93,240 matched controls. We defined the index date as the date of first recorded PD diagnosis in the Swedish Patient Register.
RESULTS: Overall, PD patients were more likely to have a previous hospitalization for CNS infections [odds ratio (OR) = 1.5, 95% confidence interval (CI): 1.2-1.9] or sepsis (OR = 1.6, 95% CI: 1.4-1.7) than controls, largely due to hospitalizations in the year before PD identification (CNS infections: OR = 3.0, 95% CI: 1.6-5.7; sepsis: OR = 3.5, 95% CI: 3.0-4.0). However, we found that subjects with multiple CNS infections at least 5 years before the index date had higher PD occurrence than those without CNS infections (OR = 3.3, 95% CI: 1.4-8.2), whereas the corresponding OR for sepsis was 1.4 (95% CI: 0.8-2.4). After the index date, PD patients were more likely to be hospitalized for CNS infections [hazard ratio (HR) =1.8, 95% CI: 1.2-2.7] or sepsis (HR = 2.2, 95% CI: 2.1-2.4) than controls.
CONCLUSIONS: This study provides preliminary evidence for an association between CNS infections, but not sepsis, and a higher future risk of PD. It also shows that PD patients were more prone to CNS infections and sepsis than controls.

Entities:  

Mesh:

Year:  2012        PMID: 22523201      PMCID: PMC3429872          DOI: 10.1093/ije/dys052

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  29 in total

1.  Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.

Authors:  Honglei Chen; Eric Jacobs; Michael A Schwarzschild; Marjorie L McCullough; Eugenia E Calle; Michael J Thun; Alberto Ascherio
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

2.  Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.

Authors:  Adina L Feldman; Anna L V Johansson; Margaret Gatz; Måns Flensburg; Giselle M Petzinger; Håkan Widner; Mark F Lew; Nancy L Pedersen; Karin Wirdefeldt
Journal:  Neuroepidemiology       Date:  2012-03-29       Impact factor: 3.282

3.  A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China.

Authors:  W Z Wang; X H Fang; X M Cheng; D H Jiang; Z J Lin
Journal:  Neuroepidemiology       Date:  1993       Impact factor: 3.282

4.  Occupation and parkinsonism in three movement disorders clinics.

Authors:  S M Goldman; C M Tanner; C W Olanow; R L Watts; R D Field; J W Langston
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

5.  Potential occupational risks for neurodegenerative diseases.

Authors:  Robert M Park; Paul A Schulte; Joseph D Bowman; James T Walker; Stephen C Bondy; Michael G Yost; Jennifer A Touchstone; Mustafa Dosemeci
Journal:  Am J Ind Med       Date:  2005-07       Impact factor: 2.214

6.  Neurodegenerative diseases: occupational occurrence and potential risk factors, 1982 through 1991.

Authors:  P A Schulte; C A Burnett; M F Boeniger; J Johnson
Journal:  Am J Public Health       Date:  1996-09       Impact factor: 9.308

7.  Measles infection and Parkinson's disease.

Authors:  A J Sasco; R S Paffenbarger
Journal:  Am J Epidemiol       Date:  1985-12       Impact factor: 4.897

8.  Parkinson's disease and the environment in early life.

Authors:  C N Martyn; C Osmond
Journal:  J Neurol Sci       Date:  1995-10       Impact factor: 3.181

9.  Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.

Authors:  P L McGeer; S Itagaki; B E Boyes; E G McGeer
Journal:  Neurology       Date:  1988-08       Impact factor: 9.910

10.  Parkinson's disease or Parkinson symptoms following seasonal influenza.

Authors:  Stephen Toovey; Susan S Jick; Christoph R Meier
Journal:  Influenza Other Respir Viruses       Date:  2011-03-21       Impact factor: 4.380

View more
  10 in total

1.  Colorectal surgery in Parkinson's disease--outcomes and predictors of mortality.

Authors:  Grace S Hwang; Monica T Young; Mark H Hanna; Gopal Menon; Michael Phelan; Joseph C Carmichael; Steven Mills; Michael J Stamos; Neal Hermanowicz; Alessio Pigazzi
Journal:  Int J Colorectal Dis       Date:  2015-06-04       Impact factor: 2.571

2.  Impact of infection on risk of Parkinson's disease: a quantitative assessment of case-control and cohort studies.

Authors:  Lei Meng; Liang Shen; Hong-Fang Ji
Journal:  J Neurovirol       Date:  2019-01-10       Impact factor: 2.643

3.  Infections or Sepsis Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study.

Authors:  Shemonti Hasan; Michelle M Mielke; J Eric Ahlskog; James Bower; Pierpaolo Turcano; Rodolfo Savica
Journal:  Mov Disord       Date:  2020-06-01       Impact factor: 10.338

4.  The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease.

Authors:  Alice J White; Ruwani S Wijeyekoon; Kirsten M Scott; Nushan P Gunawardana; Shaista Hayat; I H Solim; H T McMahon; Roger A Barker; Caroline H Williams-Gray
Journal:  Front Neurol       Date:  2018-11-20       Impact factor: 4.003

5.  The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.

Authors:  Katarzyna Z Kuter; Maria Śmiałowska; Krystyna Ossowska
Journal:  Pharmacol Rep       Date:  2021-11-11       Impact factor: 3.024

6.  Covid-19, nervous system pathology, and Parkinson's disease: Bench to bedside.

Authors:  Aron Emmi; Iro Boura; Vanessa Raeder; Donna Mathew; David Sulzer; James E Goldman; Valentina Leta
Journal:  Int Rev Neurobiol       Date:  2022-08-09       Impact factor: 4.280

7.  Association Between Tuberculosis and Parkinson Disease: A Nationwide, Population-Based Cohort Study.

Authors:  Chih-Hao Shen; Chung-Hsing Chou; Feng-Cheng Liu; Te-Yu Lin; Wen-Yen Huang; Yu-Chiao Wang; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 8.  Prevention of progression in Parkinson's disease.

Authors:  Jan Aaseth; Petr Dusek; Per M Roos
Journal:  Biometals       Date:  2018-07-20       Impact factor: 2.949

9.  Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.

Authors:  Anna Santaella; H Bea Kuiperij; Anouke van Rumund; Rianne A J Esselink; Alain J van Gool; Bastiaan R Bloem; Marcel M Verbeek
Journal:  BMC Neurol       Date:  2020-01-17       Impact factor: 2.474

10.  Endoplasmic reticulum stress regulates cell injury in lipopolysaccharide-induced nerve cells.

Authors:  Min Li; Ying Zhang; Jixing Wang
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.